{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:56Z","timestamp":1789609136855,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.clineuro.2004.12.019","type":"journal-article","created":{"date-parts":[[2005,2,8]],"date-time":"2005-02-08T15:15:25Z","timestamp":1107875725000},"page":"491-496","source":"Crossref","is-referenced-by-count":23,"title":["Factors influencing outcome in Guillain\u2013Barr\u00e9 Syndrome: comparison of plasma adsorption against other treatments"],"prefix":"10.1016","volume":"107","author":[{"given":"Takehiro","family":"Seta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nagayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichiro","family":"Katsura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Yokochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Utsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2004.12.019_bib1","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1212\/WNL.40.12.1900","article-title":"Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis","volume":"40","author":"Yuki","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2004.12.019_bib2","doi-asserted-by":"crossref","unstructured":"Kaida KI, Morita D, Kanzaki M, Kamakura K, Motoyoshi K, Hirakawa M, et al. Ganglioside complexes as new target antigens in Guillain\u2013Barre syndrome. Ann Neurol 2004;56:567\u201371.","DOI":"10.1002\/ana.20222"},{"key":"10.1016\/j.clineuro.2004.12.019_bib3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.410220612","article-title":"Efficiency of plasma exchange in Guillain\u2013Barre Syndrome: role of replacement fluids","volume":"22","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2004.12.019_bib4","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.35.8.1096","article-title":"Plasmapheresis and acute Guillain\u2013Barre Syndrome","volume":"35","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2004.12.019_bib5","first-page":"CD001798","article-title":"Plasma exchange for Guillain\u2013Barre Syndrome","author":"Raphael","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clineuro.2004.12.019_bib6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1526-0968.2002.00429.x","article-title":"Plasma adsorption in critical care","volume":"6","author":"Yang","year":"2002","journal-title":"Ther Apher"},{"key":"10.1016\/j.clineuro.2004.12.019_bib7","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain\u2013Barre Syndrome","volume":"326","author":"Van der Mech\u00e9","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clineuro.2004.12.019_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1469-7580.2002.00041.x","article-title":"Systematic reviews of treatment for inflammatory demyelinating neuropathy","volume":"200","author":"Hughes","year":"2002","journal-title":"J Anat"},{"key":"10.1016\/j.clineuro.2004.12.019_bib9","first-page":"CD002063","article-title":"Intravenous immunoglobulin for Guillain\u2013Barre Syndrome","author":"Hughes","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clineuro.2004.12.019_bib10","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM199412153312409","article-title":"Transmission of viral infections through intravenous immune globulin","volume":"331","author":"Schiff","year":"1994","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.clineuro.2004.12.019_bib11","first-page":"79","article-title":"Side-effects of intravenous immune globulins","volume":"97","author":"Duhem","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clineuro.2004.12.019_bib12","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/(SICI)1097-4598(199603)19:3<388::AID-MUS20>3.0.CO;2-N","article-title":"Complications of intravenous gammaglobulin in neuromuscular and other diseases","volume":"19","author":"Bertorini","year":"1996","journal-title":"Muscle Nerve"},{"issue":"Suppl. 1","key":"10.1016\/j.clineuro.2004.12.019_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/cei.1996.104.s1.31","article-title":"Infectious risk of plasma donations: relationship to safety of intravenous immune globulins","volume":"104","author":"Dodd","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.clineuro.2004.12.019_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/cei.1996.104.s1.35","article-title":"The viral safety of intravenous immune globulin","volume":"104","author":"Yap","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clineuro.2004.12.019_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000050777","article-title":"Study Group. A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune adsorption in Guillain\u2013Barre syndrome","volume":"46","author":"Diener","year":"2001","journal-title":"Eur Neurol"},{"key":"10.1016\/j.clineuro.2004.12.019_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0022-510X(95)00357-8","article-title":"Sequential treatment of Guillain\u2013Barre Syndrome with extracorporeal elimination and intravenous immunoglobulin","volume":"137","author":"Haupt","year":"1996","journal-title":"J Neurol Sci"},{"issue":"Suppl.","key":"10.1016\/j.clineuro.2004.12.019_bib17","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain\u2013Barre Syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2004.12.019_bib18","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.35.8.1096","article-title":"Plasmapheresis and acute Guillain\u2013Barre Syndrome","volume":"35","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2004.12.019_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0404.1994.tb01682.x","article-title":"Guillain\u2013Barre Syndrome in Cantabria Spain. An epidermiological and clinical study","volume":"89","author":"Sedano","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.clineuro.2004.12.019_bib20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/WNL.48.3.695","article-title":"Patterns of recovery in the Guillain\u2013Barre Syndromes","volume":"48","author":"Ho","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2004.12.019_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.46.1.100","article-title":"Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain\u2013Barre Syndrome","volume":"46","author":"Bril","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2004.12.019_bib22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/jnnp.63.4.494","article-title":"Guillain\u2013Barre Syndrome in Taiwan: a clinical study of 167 patients","volume":"63","author":"Lyu","year":"1997","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"10.1016\/j.clineuro.2004.12.019_bib23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jnnp.64.1.74","article-title":"Epidemiological study of Guillain\u2013Barre Syndrome in south east England","volume":"64","author":"Rees","year":"1998","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"10.1016\/j.clineuro.2004.12.019_bib24","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1468-1331.2000.00128.x","article-title":"Clinical epidemiology of Guillain\u2013Barre syndrome in adults in Sweden 1996\u20131997: a prospective study","volume":"7","author":"Cheng","year":"2000","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clineuro.2004.12.019_bib25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1212\/WNL.48.1.214","article-title":"A prospective study on the incidence and prognosis of Guillain\u2013Barre Syndrome in Emilia\u2013Romagna region Italy (1992\u20131993)","volume":"48","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2004.12.019_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.410400209","article-title":"Campylobacter jejuni infections and anti-GM1 antibodies in Guillain\u2013Barre syndrome","volume":"40","author":"Jacobs","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2004.12.019_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6","article-title":"Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain\u2013Barre syndrome","volume":"45","author":"Ho","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2004.12.019_bib28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-510X(98)00067-7","article-title":"Ability to remove immunoglobulins and anti-ganglioside antibodies by plasma exchange, double-filtration plasmapheresis and immunoadsorption","volume":"157","author":"Tagawa","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.clineuro.2004.12.019_bib29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1526-0968.2000.00182.x","article-title":"Apheresis and selective adsorption plus immunoglobulin treatment in Guillain\u2013Barre Syndrome","volume":"4","author":"Haupt","year":"2000","journal-title":"Ther Apher"},{"key":"10.1016\/j.clineuro.2004.12.019_bib30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ana.410350304","article-title":"Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease","volume":"35","author":"Thornton","year":"1994","journal-title":"Ann Neurol"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846704002197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846704002197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T22:26:36Z","timestamp":1548800796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846704002197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0303846704002197"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2004.12.019","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}